Naloxone Hydrochloride Injection, Solution
Product Images NDC 36000-310

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 36000-310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-03 (Carton 03)

This is a description of Naloxone Hydrochloride Injection, USP. It is manufactured in Taiwan and is sterile and non-pyrogenic. Each milliliter of the injection contains 0.4mg of naloxone hydrochloride, 1.8mg of methylparaben, and 0.2mg of propylparaben added as preservatives, and Sodium chloride added to adjust tonicity. It is for intravenous, intramuscular or subcutaneous use, and pH may be adjusted using HCI. The recommended dosage is mentioned in the insert, and it should be stored between 20°C to 25°C to protect it from light.*

FDA Label Image

Container-02 (Container 02)

This is a description of Naloxone Hydrochloride Injection, USP used for intravenous, intramuscular or subcutaneous use. It is sterile, non-pyrogenic, and contains Sodium Chloride to adjust tonicity. It may also contain HCI for pH adjustment, with a pH range of 3.0 to 6.5. It should be protected from light and stored at 20° to 25°C. The dosage information can be found in the insert. The manufacturer is Baxter Healthcare Corporation based in Deerfield, IL, USA. The batch number and expiry date are also mentioned in the text.*

FDA Label Image

Structure-01 (Structure 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.